🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
If a treated cancer patient cannot make antibodies to a Severe Acute Respir...
Status
Terminated
Location
Compassionate Cancer Care Medical Group
Start Date
2022-06-03
Trial ID
NCT05438498
Treatments Being Tested
To evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynami...
Status
Completed
Location
Research Site
Start Date
2021-10-09
Trial ID
NCT05437289
Treatments Being Tested
Drug studies often look at the effect one or two drugs have on a medical co...
Status
Completed
Location
Pinnacle Research Group (Site 1082), 321 E. 10th Street
Start Date
2020-08-19
Trial ID
NCT04518410
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of mRNA CO...
Status
Completed
Location
UCLA CARE Center CRS
Start Date
2021-07-09
Trial ID
NCT04952402
This study will assess the efficacy of AZD7442 for the post-exposure prophy...
Status
Completed
Location
Research Site
Start Date
2020-12-02
Trial ID
NCT04625972
This study will evaluate the pharmacokinetics (PK), pharmacodynamics (PD), ...
Status
Completed
Location
Research Site
Start Date
2022-03-21
Trial ID
NCT05281601
Treatments Being Tested
A Phase II Randomized, Open-label, Multicenter, Dose-ranging Study in Adult...
Status
Terminated
Location
Research Site
Start Date
2022-06-09
Trial ID
NCT05375760
This Phase III study will assess whether AZD7442 (a combination of 2 mAbs) ...
Status
Completed
Location
Research Site
Start Date
2021-01-28
Trial ID
NCT04723394
This study will assess the safety and efficacy of a single dose of AZD7442(...
Status
Completed
Location
Research Site
Start Date
2020-11-21
Trial ID
NCT04625725
AZD3152, a single mAb, is being developed to have broad neutralizing activi...
Status
Completed
Location
Research Site
Start Date
2022-12-16
Trial ID
NCT05648110
Treatments Being Tested